Editorial & Medical
Review Board
Every compound dossier published on BioPeptide.online is produced by qualified biochemists and independently reviewed by clinical pharmacology specialists. We adhere to strict scientific citation standards, linking directly to peer-reviewed primary literature.
Medical & Scientific Leadership
Dr. Marcus Vance
PharmD, RPh
Clinical pharmacist and pharmacokinetics consultant specializing in peptide pharmacology, receptor signaling, and preclinical safety data. Focuses on rigorous evaluation of published biochemical literature, receptor kinetics, and study methodology.
Focus & Expertise
Dr. Elena Rostova
Ph.D. Biochemistry
Molecular biochemist and peptide researcher with expertise in solid-phase peptide synthesis (SPPS), HPLC purity verification, and mass spectrometry characterization. Directs literature compilation and scientific dossier synthesis at BioPeptide.
Focus & Expertise
Our 3-Stage Scientific Review Standard
To ensure scientific integrity and eliminate unsubstantiated commercial claims, every guide undergoes a three-tiered review protocol before publishing:
Primary Literature
Claims must cite PubMed-indexed, peer-reviewed journals or official clinical trials. Secondary blog summaries and unverified forum posts are strictly excluded.
Pharmacology Analysis
Biochemists extract molecular parameters: amino acid sequence, receptor targets, half-life kinetics, and animal model dose-response ranges without hyperbole.
Medical & Toxicological Review
A credentialed medical reviewer checks the draft against consensus literature, validates adverse safety notes, and timestamps the review date.
Strict Non-Clinical Scope
BioPeptide.online publishes scientific analysis for laboratory research and educational comparison only. We do not provide human medical advice, diagnostic services, or prescriptions. All compounds referenced are intended strictly for in vitro and preclinical laboratory investigations.